Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OTHER FINANCING ACTIVITIES
Other Financing Activities URGN - UroGen Pharma Ltd.
49.6 M
LAST VALUE
-17.21%
2 YEAR CAGR
86.69%
5 YEAR CAGR
30.47%
10 YEAR CAGR